Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Health Canada approves Alprolix for hemophilia B

March 24, 2014

Canadian approval for Lemtrada

Dec. 16, 2013

Canadian approval for Bexsero meningococcal B vaccine

Dec. 10, 2013

Imvamune smallpox vaccine approved by Health Canada

Nov. 25, 2013

Simeprevir approved in Canada for chronic HCV infection

Nov. 21, 2013

Trisenox now available in Canada

Nov. 14, 2013

Canadian approval for Eylea in wet AMD

Nov. 14, 2013

Health Canada approves Opsumit for pulmonary arterial hypertension

Nov. 14, 2013

Health Canada approves Giotrif

Nov. 8, 2013

Health Canada approves Stivarga for gastrointestinal stromal tumors

Oct. 21, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...